Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane J Post

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Vaccine|April 26, 2025
Collaborative influenza vaccine innovation centers (CIVICs) programKentner L Singleton, Diane J Post, Alison D Augustine, et al.
Influenza and Other Respiratory Viruses|October 23, 2024
Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for InnovationM Chelsea Lane, Catherine J Luke, Joseph Bresee, et al.
The Journal of Infectious Diseases|March 6, 2018
A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious DiseasesEmily J Erbelding, Diane J Post, Erik J Stemmy, et al.
Vaccine|August 1, 2019
Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerationsBruce L Innis, Francesco Berlanda Scorza, Jeremy S Blum, et al.
Vaccine|August 1, 2019
Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacityBruce L Innis, Francesco Berlanda Scorza, Jeremy S Blum, et al.
Vaccine|March 9, 2020
Workshop report: Optimization of animal models to better predict influenza vaccine efficacyM Chelsea Lane, Jennifer L Gordon, Chao Jiang, et al.
Influenza and Other Respiratory Viruses|October 9, 2024
Meeting Report From "Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID-19 Pandemic"Florian Krammer, Jacqueline M Katz, Othmar G Engelhardt, et al.
Emerging Infectious Diseases|April 13, 2023
US National Institutes of Health Prioritization of SARS-CoV-2 VariantsSam Turner, Arghavan Alisoltani, Debbie Bratt, et al.
Cell Reports. Medicine|July 7, 2022
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variantKirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, et al.
NPJ Vaccines|July 11, 2023
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variantsKirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Vaccine|April 26, 2025
Collaborative influenza vaccine innovation centers (CIVICs) programKentner L Singleton, Diane J Post, Alison D Augustine, et al.
Influenza and Other Respiratory Viruses|October 23, 2024
Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for InnovationM Chelsea Lane, Catherine J Luke, Joseph Bresee, et al.
The Journal of Infectious Diseases|March 6, 2018
A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious DiseasesEmily J Erbelding, Diane J Post, Erik J Stemmy, et al.
Vaccine|August 1, 2019
Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerationsBruce L Innis, Francesco Berlanda Scorza, Jeremy S Blum, et al.
Vaccine|August 1, 2019
Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacityBruce L Innis, Francesco Berlanda Scorza, Jeremy S Blum, et al.
Vaccine|March 9, 2020
Workshop report: Optimization of animal models to better predict influenza vaccine efficacyM Chelsea Lane, Jennifer L Gordon, Chao Jiang, et al.
Influenza and Other Respiratory Viruses|October 9, 2024
Meeting Report From "Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID-19 Pandemic"Florian Krammer, Jacqueline M Katz, Othmar G Engelhardt, et al.
Emerging Infectious Diseases|April 13, 2023
US National Institutes of Health Prioritization of SARS-CoV-2 VariantsSam Turner, Arghavan Alisoltani, Debbie Bratt, et al.
Cell Reports. Medicine|July 7, 2022
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variantKirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, et al.
NPJ Vaccines|July 11, 2023
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variantsKirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, et al.
Pageof 2